These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 26609731)

  • 1. An atrial fibrosis-based approach for atrial fibrillation ablation.
    Han FT; Marrouche N
    Future Cardiol; 2015; 11(6):673-81. PubMed ID: 26609731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of magnetic resonance imaging in guiding atrial fibrillation management.
    Han FT; Akoum N; Marrouche N
    Can J Cardiol; 2013 Oct; 29(10):1194-202. PubMed ID: 24074971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.
    Marrouche NF; Wilber D; Hindricks G; Jais P; Akoum N; Marchlinski F; Kholmovski E; Burgon N; Hu N; Mont L; Deneke T; Duytschaever M; Neumann T; Mansour M; Mahnkopf C; Herweg B; Daoud E; Wissner E; Bansmann P; Brachmann J
    JAMA; 2014 Feb; 311(5):498-506. PubMed ID: 24496537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy.
    Kottkamp H
    Eur Heart J; 2013 Sep; 34(35):2731-8. PubMed ID: 23761394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional Integrated Functional, Structural, and Computational Mapping to Define the Structural "Fingerprints" of Heart-Specific Atrial Fibrillation Drivers in Human Heart Ex Vivo.
    Zhao J; Hansen BJ; Wang Y; Csepe TA; Sul LV; Tang A; Yuan Y; Li N; Bratasz A; Powell KA; Kilic A; Mohler PJ; Janssen PML; Weiss R; Simonetti OP; Hummel JD; Fedorov VV
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual electrophysiological study of atrial fibrillation in fibrotic remodeling.
    McDowell KS; Zahid S; Vadakkumpadan F; Blauer J; MacLeod RS; Trayanova NA
    PLoS One; 2015; 10(2):e0117110. PubMed ID: 25692857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial structure and function and its implications for current and emerging treatments for atrial fibrillation.
    Prabhu S; McLellan AJ; Walters TE; Sharma M; Voskoboinik A; Kistler PM
    Prog Cardiovasc Dis; 2015; 58(2):152-67. PubMed ID: 26247494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy.
    Canpolat U; Oto A; Hazirolan T; Sunman H; Yorgun H; Şahiner L; Kaya EB; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):251-9. PubMed ID: 25366936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of atrial fibrosis: redefining atrial fibrillation to a syndrome.
    Gal P; Marrouche NF
    Eur Heart J; 2017 Jan; 38(1):14-19. PubMed ID: 26409008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early recurrence of atrial fibrillation after catheter ablation with left atrial fibrosis identified at cardiac magnetic resonance by late gadolinium enhancement.
    Totaro A; Casavecchia G; Gravina M; Ieva R; Santoro F; Grimaldi M; Pellegrino PL; Macarini L; Di Biase M; Brunetti ND
    Ther Adv Cardiovasc Dis; 2016 Aug; 10(4):203-5. PubMed ID: 26826170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Left Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging: Methodology and Clinical Implications.
    Siebermair J; Kholmovski EG; Marrouche N
    JACC Clin Electrophysiol; 2017 Aug; 3(8):791-802. PubMed ID: 29759774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of left atrial imaging in the management of atrial fibrillation.
    Walters TE; Ellims AH; Kalman JM
    Prog Cardiovasc Dis; 2015; 58(2):136-51. PubMed ID: 26241303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Approaches to Atrial Fibrillation Ablation Targeting Atrial Fibrosis.
    Kottkamp H; Schreiber D; Moser F; Rieger A
    JACC Clin Electrophysiol; 2017 Jul; 3(7):643-653. PubMed ID: 29759532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.
    Oakes RS; Badger TJ; Kholmovski EG; Akoum N; Burgon NS; Fish EN; Blauer JJ; Rao SN; DiBella EV; Segerson NM; Daccarett M; Windfelder J; McGann CJ; Parker D; MacLeod RS; Marrouche NF
    Circulation; 2009 Apr; 119(13):1758-67. PubMed ID: 19307477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.
    Navaravong L; Barakat M; Burgon N; Mahnkopf C; Koopmann M; Ranjan R; Kholmovski E; Marrouche N; Akoum N
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):21-7. PubMed ID: 25142836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation.
    Gurses KM; Yalcin MU; Kocyigit D; Kesikli SA; Canpolat U; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Ozer N; Oto MA; Guc D; Aytemir K
    Europace; 2015 Feb; 17(2):239-46. PubMed ID: 25238749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI Assessment of Ablation-Induced Scarring in Atrial Fibrillation: Analysis from the DECAAF Study.
    Akoum N; Wilber D; Hindricks G; Jais P; Cates J; Marchlinski F; Kholmovski E; Burgon N; Hu N; Mont L; Deneke T; Duytschaever M; Neumann T; Mansour M; Mahnkopf C; Hutchinson M; Herweg B; Daoud E; Wissner E; Brachmann J; Marrouche NF
    J Cardiovasc Electrophysiol; 2015 May; 26(5):473-80. PubMed ID: 25727106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insights Into the Use of Cardiac Magnetic Resonance Imaging to Guide Decision Making in Atrial Fibrillation Management.
    Zghaib T; Nazarian S
    Can J Cardiol; 2018 Nov; 34(11):1461-1470. PubMed ID: 30297256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling.
    Yalcin MU; Gurses KM; Kocyigit D; Canpinar H; Canpolat U; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Tokgozoglu L; Oto MA; Ozer N; Guc D; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):635-40. PubMed ID: 25684038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrosis progression in patients with no history of atrial fibrillation.
    Dagher L; Shi H; Zhao Y; Mitlacher M; Schnupp S; Ajmi I; Forkmann M; Marrouche N; Mahnkopf C
    J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2140-2147. PubMed ID: 34191382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.